Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Gains from Investment Securities (2024 - 2025)

Historic Gains from Investment Securities for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Q1 2025 value amounting to $230000.0.

  • Day One Biopharmaceuticals' Gains from Investment Securities changed N/A to $230000.0 in Q1 2025 from the same period last year, while for Sep 2025 it was $230000.0, marking a year-over-year decrease of 9099.45%. This contributed to the annual value of $2.6 million for FY2024, which is N/A changed from last year.
  • Day One Biopharmaceuticals' Gains from Investment Securities amounted to $230000.0 in Q1 2025.
  • Day One Biopharmaceuticals' Gains from Investment Securities' 5-year high stood at $2.6 million during Q3 2024, with a 5-year trough of $230000.0 in Q1 2025.